Autoimmune-induced preferential depletion of myelin-associated glycoprotein (MAG) is genetically regulated in relapsing EAE (B6 x SJL) F1 mice

Molecular Neurodegeneration

Volumn 3, Issue 1, 2008, Pages

  Skundric, Dusanka S ^a   Dai, Rujuan ^a   Zakarian, Vaagn L ^b   Zhou, Weili ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The University of Colorado Denver   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 47349090805     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-3-7     Document Type: Article

References (40)

1. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. H Lassmann W Bruck C Lucchinetti, Trends Mol Med 2001 7 115 21 10.1016/S1471-4914(00)01909-2 11286782
2. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. CF Lucchinetti W Bruck M Rodriguez H Lassmann, Brain Pathol 1996 6 259 74 10.1111/j.1750-3639.1996.tb00854.x 8864283
3. Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? M Rodriguez CF Lucchinetti, Neurol 1999 53 1615 6 10563600
4. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. S Issazadeh K Abdallah T Chitnis A Chandraker AD Wells LA Turka MH Sayegh SJ Khoury, J Clin Inves 2000 105 8 1109 16 10.1172/JCI8607 10772655
5. Pathogenesis of tissue injury in MS lesions. BD Trapp L Bo S Mork A Chang, J Neuroimmunol 1999 98 49 56 10.1016/S0165-5728(99)00081-8 10426362
6. NF-M is an essential target for the myelin-directed "outside- in" signaling cascade that mediates radial axonal growth. ML Garcia CS Lobsiger SB Shah TJ Deerinck J Crum D Young CM Ward TO Crawford T Gotow Y Uchiyama MH Ellisman NA Calcutt DW Cleveland, J Cell Biol 2003 163 1011 20 14662745 10.1083/jcb.200308159
7. The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate. MV Rao J Campbell A Yuan A Kumar T Gotow Y Uchiyama RA Nixon, J Cell Biol 2003 163 1021 31 14662746 10.1083/jcb.200308076
8. b/s mice. DS Skundric V Zakarian R Dai R Lisak J James, J Neuroimmunol 2003 136 34 45 10.1016/S0165-5728(03)00005-5 12620641
9. Induction of multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte protein. A Slavin C Ewing J Liu M Ichiakawa J Slavin CC Bernard, Autoimmunity 1988 28 109 15 10.3109/08916939809003872 9771980
10. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 × SJL) F1 mice. GX Zhang S Yu B Gran J Li D Calida E Ventura X Chen A Rostami, J Neuroimmuno 2004 148 1-2 1 10 10.1016/j.jneuroim.2003.10.057 14975581
11. Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. I Tsunoda RS Fujinami, Springer Semin Immunopathol 2002 24 105 125 10.1007/s00281-002-0105-z 12503060
12. Multiple sclerosis- the plaque and its pathogenesis. EM Frohman MK Racke CS Raine, N Engl J Med 2006 354 9 942 955 10.1056/NEJMra052130 16510748
13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. DS Skundric R Dai VL Zakarian D Bessert RP Skoff WW Cruikshank Z Kurjakovic, J Neurosci Res 2005 79 680 93 10.1002/jnr.20377 15682385
14. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. B Kornek MK Storch R Weissert E Wallstroem A Stefferl T Olsson C Linington M Schmidbauer H Lassmann, Am J Pathol 2000 157 267 76 10880396
15. Myelin-associated glycoprotein (MAG): past, present and beyond. RH Quarles, J Neurochem 2007 100 1431 48 17241126
16. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. F Aboul-Enein H Rauschka B Kornek C Stadelmann A Stefferl W Bruck C Lucchinetti M Schmidbauer K Jellinger H Lassmann, J Neuropathol Exp Neurol 2003 62 25 33 12528815
17. Immunological aspects of axon injury in multiple sclerosis. CL Howe, Curr Top Microbiol Immunol 2008 318 93 13 18219816
18. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Y Itoyama NH Sternberger HD Webster RH Quarles SR Cohen EP Richardson Jr, Ann Neurol 1980 7 167 77 10.1002/ana.410070212 6154440
19. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. MH Barnett JW Prineas, Ann Neurol 2004 55 458 68 10.1002/ana.20016 15048884
20. Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. SJ Jackson G Pryce LT Diemel ML Cuzner D Baker, Neuroscience 2005 134 261 8 10.1016/j.neuroscience.2005.02.045 15953683
21. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS. AA Musse G Harauz, Int Rev Neurobiol 2007 79 149 72 17531841
22. Experimental models of relapsing-remitting multiple sclerosis: Current concepts and perspective. DS Skundric, Curr Neurovasc Res 2005 2 349 62 10.2174/156720205774322601 16181126
23. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. M Khare A Mangalam M Rodriguez CS David, J Neuroimmunol 2005 169 1 12 10.1016/j.jneuroim.2005.07.023 16194572
24. Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis. PM Mathisen JA Kawczak M Yu JM Johnson VK Tuohy, J Neurosci Res 2001 64 542 51 10.1002/jnr.1106 11391709
25. Quantification of neurodegeneration by measurement of brain-specific proteins. A Petzold D Baker G Pryce G Keir EJ Thompson G Giovannoni, J Neuroimmunol 2003 138 45 8 10.1016/S0165-5728(03)00092-4 12742652
26. Production of IL-16 Correlates with CD4+ Th1 Inflammation and Phosphorylation of Axonal Cytoskeleton in Multiple Sclerosis (MS) Lesions. DS Skundric J Cai WW Cruikshank D Gveric, J Neuroinflammation 2006 3 13 16729885 10.1186/1742-2094-3-13
27. Absence of the Mid-sized Neurofilament Subunit Decreases Axonal Calibers, Levels of Light Neurofilaments (NF-L), and Neurofilament Content. GA Elder VL Friedrich P Bosco C Kang A Gourov T Pang-Hsien VM Lee RA Lazzarini, J Cell Biol 1998 141 3 727 739 10.1083/jcb.141.3.727 9566972
28. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. LP Shriver BN Dittel, Am J Pathol 2006 169 3 999 1011 16936273 10.2353/ajpath.2006.050791
29. Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. S Weerth H Rus M Shin C Raine, Am J Pathol 2003 163 3 1069 1080 12937147
30. Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice. DS Skundric C Kim HY Tse CS Raine, J Neuroimmunol 2003 46 1-2 113 122 10.1016/0165-5728(93)90240-Y 7689581
31. Experimental allergic encephalomyelitis: T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. DS Skundric K Huston M Shaw H Tse CS Raine, Lab Invest 1994 71 671 679 7526038
32. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. W Bruck, J Neurol 2005 252 Suppl 5 v3 9 10.1007/s00415-005-5002-7 16254699
33. Microglia and neuroinflammation: a pathological perspective. WJ Streit RE Mrak WS Griffin, J Neuroinflammation 2004 1 14 15285801 10.1186/1742-2094-1-14
34. MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury. MK Storch R Weissert A Steffer R Birnbacher E Wallstrom I Dahlman CG Ostensson C Linington T Olsson H Lassmann, Brain Pathol 2002 12 287 99 12146797
35. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. P Bannerman A Hahn A Soulika V Gallo D Pleasure, Glia 2007 55 57 64 10.1002/glia.20437 17009237
36. The suppression of T cell apoptosis influences the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice. Y Okuda M Okuda CC Bernard, J Neuroimmunol 2002 131 115 25 10.1016/S0165-5728(02)00267-9 12458043
37. Poly ADP ribose-polymerase inhibitors prevent the up-regulation of ICAM-1 and E-selectin in response to Th1 cytokine stimulation. C Sharp A Warren T Oshima L Williams JH Li JS Alexander, Inflammation 2001 25 157 163 10.1023/A:1011032313445 11403206
38. Poly(ADP-Ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. A Chiarugi MA Moskowitz, J Neurochem 2003 85 2 306 317 10.1046/j.1471-4159.2003.01684.x 12675907
39. Poly(ADP-Ribose) Polymerase-1 Activation in a Primate Model of Multiple Sclerosis. TM Kauppinen SW Suh CP Genain RA Swanson, J Neurosci Res 2005 81 190 198 10.1002/jnr.20525 15931673
40. Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE). DS Skundric W Zhou WW Cruikshank R Dai, J Autoimmun 2005 25 206 14 10.1016/j.jaut.2005.09.016 16271292